Roche has announced that its Elecsys beta-Amyloid (1-42) CSF II (Abeta42) and Elecsys Phospho-Tau (181P) CSF (pTau181) assays have received US Food and Drug Administration (FDA) 510(k) clearance.
AI cancer diagnostics firm Ibex Medical and Source LDPath have announced a new agreement to expand the deployment of artificial intelligence to the entire pathology network at Source.
The IBMS has submitted evidence to the Public Accounts Committee's inquiry into managing NHS backlogs and waiting times, as part of its commitment to supporting the profession from the ground up and having an impact on government policy.
The Laboratory of Pathology at Dordrecht, Netherlands is to collaborate with PreciseDx by studying the performance of PreciseDx’s AI-driven Cancer Risk Stratification platform, confirming its accuracy of staging and role in the decision process.
BC Platforms has announced that, together with Finland’s Euformatics and Hungary’s Oncompass Medicine, the BCP-led partnership has been awarded a contract for the second phase of developing standardised oncology workflows for a consortium of seven leading central European hospitals, represented by the Medical University Graz.
BIOHIT HealthCare has announced a new partnership with Celltrion Healthcare UK, providing point-of-care assays for the Celltrion Connect Dedicated Homecare Service, which is designed to support patients with inflammatory bowel disease (IBD) and their healthcare providers.
Metrion Biosciences Limited has recently launched its high-throughput screening (HTS) capability, coinciding with the expansion of its state-of-the-art laboratory and office facilities.
Dudley’s laboratory implements the WinPath Enterprise laboratory information system and the latest version of ICE order communications and results reporting in a ‘big bang’ deployment
Winter is always a difficult time for blood stocks. Avoidable transfusion and inappropriate use of O D-negative red blood cells remain a challenge for organisations, particularly considering the recent Amber alert issued by NHS Blood & Transplant. Join this webinar on Tuesday 6 December 2022 (13:00–14:00 GMT) where SHOT Working Expert Group members and representatives from the four UK Blood Services will provide an overview of Patient Blood Management (PBM) activities and share key learning points.
Digital technologies will play a vital role in ensuring the NHS workforce can cope with future demands on the system, according to a new report by Health Education England.
The Native Antigen Company (part of LGC Clinical Diagnostics) has made two key appointments to its management team. Richard White has joined the company as Business Development Manager, and Pardeep Sharda as Senior Product Manager.
US health body the National Institutes of Health (NIH) has launched a new website to make it easier to report a positive or negative COVID-19 test result.
Molecular diagnostics firm Sense Biodetection has announced a new partnership with R-Biopharm. for the non-exclusive distribution in the Netherlands, Belgium, and Luxembourg of Sense’s Veros instrument-free, point-of-care molecular testing platform.
Aquyre Biosciences has recognised Lung Cancer Awareness Month by reaching a milestone of over 400 lung biopsy procedures completed using the CelTivity microscopy system.